GlycoErase™ HEK293T SLC35C1 Knockout Cell Line (CAT#: GLJF-0425-JF466)

Description	For researchers investigating GDP-fucose transport and glycosylation disorders, we are pleased to offer an SLC35C1 knockout HEK293T cell line. This cell line lacks the SLC35C1-encoded GDP-fucose transporter, a protein found in the Golgi apparatus. This model provides a valuable tool for understanding the role of SLC35C1 in GDP-fucose transport and its impact on glycosylation processes.
Product Type	KO Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:2~1:4
Cell Line	HEK293T
Lineage	Embryonic kidney

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	PCR, Sanger Sequencing
Culture Medium	DMEM & FBS & Penicillin/Streptomycin
Application	Functional assay
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	SLC35C1
Full Name	Solute carrier family 35 member C1
Alternative Name	FLJ11320, FUCT1
Location	11p11.2
Gene ID	55343
Summary	Encodes a GDP-fucose transporter located in the Golgi apparatus; mutations in this gene can disrupt glycosylation processes and lead to congenital disorder of glycosylation type IIc.